Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gandini

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Journal of the National Cancer Institute|October 17, 1998
Biologic activity of tamoxifen at low doses in healthy womenA Decensi, B Bonanni, A Guerrieri-Gonzaga, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 28, 2019
Association of sunbed use with skin cancer risk factors in Europe: an investigation within the Euromelanoma skin cancer prevention campaignM Suppa, S Gandini, H Njimi, et al.
British Journal of Cancer|May 27, 2015
Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patientsP F Ferrucci, S Gandini, A Battaglia, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 28, 2019
Prevalence and determinants of sunbed use in thirty European countries: data from the Euromelanoma skin cancer prevention campaignM Suppa, S Gandini, H Njimi, et al.
ESMO Open|August 3, 2024
Interstitial lung disease in patients enrolled in early-phase clinical trials: the ILDE studyD Trapani, R Scalia, E Giordano, et al.
NPJ Breast Cancer|June 9, 2025
Window-of-opportunity trials to screen effective agents and optimize dose in breast cancer preventionG Aurilio, D Serrano, M Lazzeroni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2017
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumabP F Ferrucci, P A Ascierto, J Pigozzo, et al.
British Journal of Cancer|September 22, 2012
Diabetes and breast cancer risk: a meta-analysisP Boyle, M Boniol, A Koechlin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2016
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumabP F Ferrucci, P A Ascierto, J Pigozzo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 12, 2021
Management of breast cancer patients during the peak of the COVID 19 pandemicE Montagna, F Bellerba, C Sangalli, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Journal of the National Cancer Institute|October 17, 1998
Biologic activity of tamoxifen at low doses in healthy womenA Decensi, B Bonanni, A Guerrieri-Gonzaga, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 28, 2019
Association of sunbed use with skin cancer risk factors in Europe: an investigation within the Euromelanoma skin cancer prevention campaignM Suppa, S Gandini, H Njimi, et al.
British Journal of Cancer|May 27, 2015
Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patientsP F Ferrucci, S Gandini, A Battaglia, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 28, 2019
Prevalence and determinants of sunbed use in thirty European countries: data from the Euromelanoma skin cancer prevention campaignM Suppa, S Gandini, H Njimi, et al.
ESMO Open|August 3, 2024
Interstitial lung disease in patients enrolled in early-phase clinical trials: the ILDE studyD Trapani, R Scalia, E Giordano, et al.
NPJ Breast Cancer|June 9, 2025
Window-of-opportunity trials to screen effective agents and optimize dose in breast cancer preventionG Aurilio, D Serrano, M Lazzeroni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2017
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumabP F Ferrucci, P A Ascierto, J Pigozzo, et al.
British Journal of Cancer|September 22, 2012
Diabetes and breast cancer risk: a meta-analysisP Boyle, M Boniol, A Koechlin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2016
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumabP F Ferrucci, P A Ascierto, J Pigozzo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 12, 2021
Management of breast cancer patients during the peak of the COVID 19 pandemicE Montagna, F Bellerba, C Sangalli, et al.
Pageof 8